Projects per year
Personal profile
Expertise related to UN Sustainable Devlopment Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
TriKE, Biology, Optimization, Improved Administration, and GMP Manufacturing Support
6/16/21 → 6/30/23
Project: Research project
-
Leveraging low oxygen environments for improved Natural Killer cell immunotherapy
Kennedy, P., Felices, M., Lou, E., Luo, X. & Miller, J. S.
5/1/21 → 10/31/23
Project: Research project
-
NK cells, their receptors, and cancer therapy
Miller, J. S., Bachanova, V., Basu, S., Brunstein, C. G., Cichocki, F. M., Felices, M., Geller, M. A., Grzywacz, B. J., Le, C. T., Luo, X., Starr, T., Walcheck, B., Warlick, E. D. & Weisdorf, D. J.
NIH NATIONAL CANCER INSTITUTE (NCI)
4/9/21 → 3/31/26
Project: Research project
-
Expression of recombinant Fc receptors by engineered NK cells to enhance cancer cell killing
Walcheck, B., Geller, M. A., Miller, J. S., Moriarity, B. S., Rendahl, A., Starr, T. & Wu, J.
NIH NATIONAL CANCER INSTITUTE (NCI)
4/1/21 → 3/31/26
Project: Research project
-
Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation
Mishra, H. K., Dixon, K. J., Pore, N., Felices, M., Miller, J. S. & Walcheck, B., Jul 22 2021, In: Frontiers in immunology. 12, 711621.Research output: Contribution to journal › Article › peer-review
Open Access -
Bi-specific and Tri-specific NK Cell Engagers: The New Avenue of Targeted NK Cell Immunotherapy
Phung, S. K., Miller, J. S. & Felices, M., Sep 2021, In: Molecular Diagnosis and Therapy. 25, 5, p. 577-592 16 p.Research output: Contribution to journal › Review article › peer-review
-
Cellular Immunotherapy—Highlights from TCT 2021
Reshef, R., Muranski, P. & Miller, J. S., Jul 1 2021, In: Transplantation and Cellular Therapy. 27, 7, p. 527-532 6 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Cytomegalovirus-Specific Immunity Recovers More Slowly after Cord Blood Transplantation Compared with Matched Sibling Donor Allogeneic Transplantation
Bejanyan, N., Vlasova-St Louis, I., Mohei, H., Cao, Q., El Jurdi, N., Wagner, J. E., Miller, J. S. & Brunstein, C. G., Feb 2021, In: Transplantation and Cellular Therapy. 27, 2, p. 187.e1-187.e4Research output: Contribution to journal › Article › peer-review
Open Access -
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer
Ragoonanan, D., Khazal, S. J., Abdel-Azim, H., McCall, D., Cuglievan, B., Tambaro, F. P., Ahmad, A. H., Rowan, C. M., Gutierrez, C., Schadler, K., Li, S., Di Nardo, M., Chi, L., Gulbis, A. M., Shoberu, B., Mireles, M. E., McArthur, J., Kapoor, N., Miller, J., Fitzgerald, J. C. & 22 others, , Jul 2021, In: Nature Reviews Clinical Oncology. 18, 7, p. 435-453 19 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations
Press / Media
-
University of Minnesota turns natural killer cells against COVID-19
Joshua R Rhein & Jeffrey S Miller
8/6/20
1 item of Media coverage
Press/Media: Expert Comment